Mortality of patients with COPD participating in chronic disease management programmes: a happy end?
Fiche du document
2014
- doi: 10.1136/thoraxjnl-2013-204983
- issn: 0040-6376
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1136/thoraxjnl-2013-204983
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/24718640
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1468-3296
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_C3BA0120A0C70
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
Patients--Mortality Mortality, Law ofCiter ce document
I. Peytremann-Bridevaux et al., « Mortality of patients with COPD participating in chronic disease management programmes: a happy end? », Serveur académique Lausannois, ID : 10.1136/thoraxjnl-2013-204983
Métriques
Partage / Export
Résumé
BACKGROUND: Concerns about increased mortality could question the role of COPD chronic disease management (CDM) programmes. We aimed at extending a recent Cochrane review to assess the effects of CDM on mortality in patients with COPD. METHODS: Mortality data were available for 25 out of 29 trials identified in a COPD integrated care systematic review. Meta-analysis using random-effects models was performed, followed by subgroup analyses according to study length (3-12 months vs >12 months), main intervention component (exercise, self-management, structured follow-up) and use of an action plan. RESULTS: The meta-analysis showed no impact of CDM on mortality (pooled OR: 1.00, 95% CI 0.79 to 1.28). CONCLUSIONS: These results do not suggest that CDM programmes expose patients with COPD to excessive mortality risk.